Table 10.6g

Immunosuppression Use for Maintenance Between Discharge

and One Year Following Transplantation, 1994 to 2003

Recipients with Intestine Transplants

  Year of Transplant
1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
Transplants 23 46 45 68 70 73 81 111 107 116
Tx with Follow-up Immunosuppression Info 12 22 27 31 34 37 54 68 73 87
Corticosteroids Any in Category 100.0% 90.9% 100.0% 93.5% 97.1% 100.0% 100.0% 85.3% 91.8% 83.9%
Steroids 100.0% 90.9% 100.0% 93.5% 97.1% 100.0% 100.0% 85.3% 91.8% 83.9%
Cyclosporine Any in Category 25.0% 13.6% 11.1% 6.5% 2.9% 2.7% 0.0% 0.0% 1.4% 0.0%
Cyclosporin 25.0% 4.5% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Sandimmmune 0.0% 0.0% 0.0% 0.0% 0.0% 2.7% 0.0% 0.0% 1.4% 0.0%
Neoral 0.0% 9.1% 11.1% 6.5% 2.9% 0.0% 0.0% 0.0% 0.0% 0.0%
Tacrolimus Any in Category 83.3% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 98.9%
Tacrolimus 83.3% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 98.9%
Antimetabolites Any in Category 16.7% 54.5% 66.7% 29.0% 41.2% 37.8% 14.8% 16.2% 11.0% 9.2%
Mycophenolate Mofetil 0.0% 18.2% 44.4% 12.9% 35.3% 21.6% 14.8% 2.9% 9.6% 9.2%
Azathioprine 16.7% 36.4% 22.2% 16.1% 5.9% 16.2% 0.0% 13.2% 1.4% 0.0%
mTOR Inhibitors Any in Category 0.0% 0.0% 0.0% 0.0% 0.0% 21.6% 70.4% 25.0% 28.8% 16.1%
Sirolimus 0.0% 0.0% 0.0% 0.0% 0.0% 21.6% 70.4% 25.0% 28.8% 16.1%
Everolimus 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%


Source: OPTN/SRTR Data as of May 2, 2005.

Percentages are calculated based on the total number of patients with any immunosuppression use between discharge and one year following transplantation.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may be prescribed more than one drug withinthe same category.